BNT162b2B.1.617SARS-CoV-2

Jianying Liu1,2, Yang Liu3, Hongjie Xia3

  • 1Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.

Nature
|June 10, 2021
PubMed
概括

接种了BNT162b2 (Pfizer-BioNTech) 中和SARS-CoV-2变种的人的血清. 这一发现支持大规模免疫作为控制COVID-19流行病的关键策略.